Tintinalli's ER Manual is a portable, offline-accessible clinical reference app for emergency medicine professionals on iOS.
The App DNA
What makes this app unique?
Clinicians hire this tool for rapid, reliable triage information in high-acuity settings where network connectivity is unreliable or unavailable.
For Clinicians and healthcare professionals working in acute care and emergency medicine settings.
What does it look like?
Key features
Full text and image retrieval available without an active internet connection after initial download.
Search tool provides suggestions as the user types and retains history for rapid retrieval of past topics.
Users can create notes and bookmarks for specific chapters and images.
Layout adjusts automatically for phone or tablet screen sizes.
How much does it cost?
Paid model anchored at $49.99, positioning the app as a professional medical reference tool rather than a consumer utility.
Velocity
Steady developmentShow more...
Who built it?
Usatine & Erickson Media
13+ apps tracked · Medical
Crush Step 3 CCS: USMLE Review
Dermoscopy Criteria Review
Atlas Emergency Ultrasound, 2E
Color Atlas Cosmetic Derm, 2/E
Schwartz’s Surgery 11/E
Pediatrics CCS USMLE Step 3
Clinical Anesthesiology, 7/E
Lichtman's Atlas of Hematology
Fitzpatricks Atlas/Synopsis 9E
Johns Hopkins Internal Med 5/E
Greenspan's Endocrinology 10/E
Dermatologic Drug Therapy, 3/EUser Sentiment
What do users think recently?
Fresh user feedback skews upset.
How are ratings & reviews evolving?
What users say, by theme
- Aggressive paywall structures prevent access to core features after the initial purchase price
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Tintinalli's ER Manual
How's the Medical market?
The app occupies a niche professional reference space, but the lack of recent rating volume and the high price point relative to free alternatives like Merck Manual limits its market reach.
Read the market outlookThe rivals identified
By UpToDate, Inc.
UpToDate is the industry-standard clinical decision support tool, serving the same professional audience as Tintinalli’s with a massive, frequently updated evidence-based repository.
- Maintains a massive, peer-reviewed clinical database that updates daily to reflect current medical evidence.
- Offers deep integration with hospital electronic health records, creating a sticky enterprise-level distribution moat.
- Provides comprehensive clinical calculators and drug interaction tools directly within the primary search workflow.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Tintinalli's ER Manual
Where is it heading?
The professional medical reference market is consolidating around enterprise-integrated tools that offer daily evidence updates, leaving static manuals like this one increasingly isolated. Unless the app shifts to a high-utility, calculator-integrated, or enterprise-licensed model, it will continue to lose ground to free and integrated competitors.
- The latest update failed to address subscription complaints, which compounds the negative sentiment and prevents new user conversion.
- Static content updates cannot compete with the daily evidence-based streams of UpToDate, leading to long-term relevance decay.
The SWOT
- Offline-first architecture ensures utility in high-acuity clinical zones without network access.
- Personalized annotation layers increase switching costs for power users.
- Pivot to an enterprise-licensing model to bypass individual clinician friction.
- Integrate clinical calculators to increase daily utility.
Next best moves
Remove the subscription paywall for existing purchasers because user sentiment is 100% negative regarding double-dipping → restore trust baseline.
+ 1 more prioritized moveThe counter-intuitive read
The app's biggest threat is not the comprehensive UpToDate database, but free…
Read the full takeFeature gaps
Evidence-based daily updates (available in UpToDate but absent here) +1
Since the last report: The app's competitive position has declined due to aggressive subscription demands and a failure to address user complaints, leading to a negative sentiment trend.
Bottom line
Users report: The app provides high-utility clinical content but suffers from a predatory monetization model that alienates its professional user base, so the PM must prioritize removing subscription friction to prevent total brand erosion.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated